Your browser doesn't support javascript.
loading
A pathology foundation model for cancer diagnosis and prognosis prediction.
Wang, Xiyue; Zhao, Junhan; Marostica, Eliana; Yuan, Wei; Jin, Jietian; Zhang, Jiayu; Li, Ruijiang; Tang, Hongping; Wang, Kanran; Li, Yu; Wang, Fang; Peng, Yulong; Zhu, Junyou; Zhang, Jing; Jackson, Christopher R; Zhang, Jun; Dillon, Deborah; Lin, Nancy U; Sholl, Lynette; Denize, Thomas; Meredith, David; Ligon, Keith L; Signoretti, Sabina; Ogino, Shuji; Golden, Jeffrey A; Nasrallah, MacLean P; Han, Xiao; Yang, Sen; Yu, Kun-Hsing.
Affiliation
  • Wang X; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
  • Zhao J; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.
  • Marostica E; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
  • Yuan W; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Jin J; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
  • Zhang J; Division of Health Sciences and Technology, Harvard-Massachusetts Institute of Technology, Boston, MA, USA.
  • Li R; College of Biomedical Engineering, Sichuan University, Chengdu, China.
  • Tang H; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wang K; College of Biomedical Engineering, Sichuan University, Chengdu, China.
  • Li Y; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.
  • Wang F; Department of Pathology, Shenzhen Maternity & Child Healthcare Hospital, Shenzhen, China.
  • Peng Y; Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing, China.
  • Zhu J; Department of Pathology, Chongqing University Cancer Hospital, Chongqing, China.
  • Zhang J; Department of Pathology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
  • Jackson CR; Department of Pathology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Zhang J; Department of Burn, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Dillon D; College of Biomedical Engineering, Sichuan University, Chengdu, China.
  • Lin NU; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
  • Sholl L; Department of Pathology and Laboratory Medicine, Pennsylvania State University, Hummelstown, PA, USA.
  • Denize T; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Meredith D; Tencent AI Lab, Shenzhen, China.
  • Ligon KL; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Signoretti S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ogino S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Golden JA; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Nasrallah MP; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Han X; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Yang S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Yu KH; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Nature ; 2024 Sep 04.
Article in En | MEDLINE | ID: mdl-39232164
ABSTRACT
Histopathology image evaluation is indispensable for cancer diagnoses and subtype classification. Standard artificial intelligence methods for histopathology image analyses have focused on optimizing specialized models for each diagnostic task1,2. Although such methods have achieved some success, they often have limited generalizability to images generated by different digitization protocols or samples collected from different populations3. Here, to address this challenge, we devised the Clinical Histopathology Imaging Evaluation Foundation (CHIEF) model, a general-purpose weakly supervised machine learning framework to extract pathology imaging features for systematic cancer evaluation. CHIEF leverages two complementary pretraining methods to extract diverse pathology representations unsupervised pretraining for tile-level feature identification and weakly supervised pretraining for whole-slide pattern recognition. We developed CHIEF using 60,530 whole-slide images spanning 19 anatomical sites. Through pretraining on 44 terabytes of high-resolution pathology imaging datasets, CHIEF extracted microscopic representations useful for cancer cell detection, tumour origin identification, molecular profile characterization and prognostic prediction. We successfully validated CHIEF using 19,491 whole-slide images from 32 independent slide sets collected from 24 hospitals and cohorts internationally. Overall, CHIEF outperformed the state-of-the-art deep learning methods by up to 36.1%, showing its ability to address domain shifts observed in samples from diverse populations and processed by different slide preparation methods. CHIEF provides a generalizable foundation for efficient digital pathology evaluation for patients with cancer.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nature / Nature (Lond.) / Nature (London) Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nature / Nature (Lond.) / Nature (London) Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido